Quick Order

VEGF / VEGFA / VEGF165 Antibody, Rabbit PAb

    DatasheetReviewsRelated ProductsProtocols
    Human VEGF-A Antibody Product Information
    Immunogen:Recombinant Human VEGF165 protein (Catalog#11066-HNAB)
    Clone ID:
    Ig Type:Rabbit IgG
    Concentration:
    Formulation:0.2 μm filtered solution in PBS with 5% trehalose
    Preparation:Produced in rabbits immunized with purified, recombinant Human VEGF165 (rh VEGF 165; Catalog#11066-HNAB; P15692-4; Met 1-Arg 191). Total IgG was purified by Protein A affinity chromatography.
    Other VEGF-A Antibody Products
    Reactivity: Human  
    Application: ELISA  
      10009-RP01-400
      10009-RP01-200
      10009-RP01-100
      400 µg 
      200 µg 
      100 µg 
      Add to Cart
      Reactivity: Human  
      Application: ELISA  
      • Slide 1
      10008-RP02-50
      10008-RP02-200
      10008-RP02-100
      50 µg 
      200 µg 
      100 µg 
      Add to Cart
      Reactivity: Human  
      Application: ELISA  
        11066-T16-50
        11066-T16-200
        11066-T16-100
        50 µg 
        200 µg 
        100 µg 
        Add to Cart
        Reactivity: Human  
        Application: ELISA  
        • Slide 1
        10008-RP01-400
        10008-RP01-200
        10008-RP01-100
        400 µg 
        200 µg 
        100 µg 
        Add to Cart
        Reactivity: Human  
        Application: WB  IP  
        • Slide 1
        • Slide 1
        100253-T36-50
        100253-T36-200
        100253-T36-100
        50 µg 
        200 µg 
        100 µg 
        Add to Cart
        Reactivity: Human  
        Application: ELISA  WB  IHC-P  
        • Slide 1
        • Slide 1
        10009-RP02-50
        10009-RP02-200
        10009-RP02-100
        50 µg 
        200 µg 
        100 µg 
        Add to Cart
        Reactivity: Human  
        Application: 
          10008-R145-50
          10008-R145-100
          10008-R145-1
          50 µg 
          100 µg 
          1 mg 
          Add to Cart
          Reactivity: Human  
          Application: ELISA  
            10008-R064-50
            10008-R064-100
            10008-R064-1
            50 µg 
            100 µg 
            1 mg 
            Add to Cart
            Reactivity: Human  
            Application: B/N  
            • Slide 1
            11066-R010-500
            11066-R010-200
            500 µg 
            200 µg 
            Add to Cart
            Reactivity: Human  
            Application: ELISA  
              11066-RP02-50
              11066-RP02-200
              11066-RP02-100
              50 µg 
              200 µg 
              100 µg 
              Add to Cart
              Reactivity: Human  
              Application: B/N  
              • Slide 1
              11066-R012-500
              11066-R012-200
              500 µg 
              200 µg 
              Add to Cart
              Reactivity: Human  
              Application: ELISA  
                11066-R105-50
                11066-R105-100
                50 µg 
                100 µg 
                Add to Cart
                Reactivity: Mouse  
                Application: ELISA  
                  50159-T16-50
                  50159-T16-200
                  50159-T16-100
                  50 µg 
                  200 µg 
                  100 µg 
                  Add to Cart
                  Reactivity: Mouse  
                  Application: ELISA  
                    50159-RP01-400
                    50159-RP01-200
                    50159-RP01-100
                    400 µg 
                    200 µg 
                    100 µg 
                    Add to Cart
                    Reactivity: Rat  
                    Application: ELISA  
                      80006-R003-50
                      80006-R003-100
                      50 µg 
                      100 µg 
                      Add to Cart
                      Reactivity: Rat  
                      Application: ELISA  
                        80006-RP01-400
                        80006-RP01-200
                        80006-RP01-100
                        400 µg 
                        200 µg 
                        100 µg 
                        Add to Cart
                        Reactivity: Rat  
                        Application: 
                          80006-R001-50
                          80006-R001-100
                          80006-R001-1
                          50 µg 
                          100 µg 
                          1 mg 
                          Add to Cart
                          Reactivity: Rat  
                          Application: ELISA  
                            80006-T16-50
                            80006-T16-200
                            80006-T16-100
                            50 µg 
                            200 µg 
                            100 µg 
                            Add to Cart
                            Immunochemical staining of human CCNF in human brain with rabbit polyclonal antibody (1 µg/mL, formalin-fixed paraffin embedded sections).
                            VEGF/VEGFA Background

                            Vascular endothelial growth factor (VEGF), also known as vascular permeability factor (VPF) and VEGF-A, is a potent mediator of both angiogenesis and vasculogenesis in the fetus and adult. It is a member of the platelet-derived growth factor (PDGF)/vascular endothelial growth factor (VEGF) family and often exists as a disulfide-linked homodimer. VEGF-A protein is a glycosylated mitogen that specifically acts on endothelial cells and has various effects, including mediating increased vascular permeability, inducing angiogenesis, vasculogenesis and endothelial cell growth, promoting cell migration, inhibiting apoptosis and tumor growth. VEGF-A protein is also a vasodilator that increases microvascular permeability, thus it was originally referred to as vascular permeability factor.

                            Immune Checkpoint   Immunotherapy   Cancer Immunotherapy   Targeted Therapy

                            Human VEGF/VEGFA References
                          • Woolard J. et al. (2004) VEGF165b, an inhibitory vascular endothelial growth factor splice variant: mechanism of action, in vivo effect on angiogenesis and endogenous protein expression. Cancer Res. 64(21): 7822-7835.
                          • Jia SF, et al. (2008) VEGF165 is necessary to the metastatic potential of Fas(-) osteosarcoma cells but will not rescue the Fas(+) cells. J Exp Ther Oncol. 7(2): 89-97.
                          • Cimpean AM, et al. (2008) Vascular endothelial growth factor A (VEGF A) as individual prognostic factor in invasive breast carcinoma. Rom J Morphol Embryol. 49(3): 303-8.
                          • Hamdollah Zadeh MA, et al. (2008) VEGF-mediated elevated intracellular calcium and angiogenesis in human microvascular endothelial cells in vitro are inhibited by dominant negative TRPC6. Microcirculation. 15(7): 605-14.
                          • Eisenach PA, et al. (2010) MT1-MMP regulates VEGF-A expression through a complex with VEGFR-2 and Src. J Cell Sci. 123(Pt 23):4182-4193.
                          • Claesson-Welsh L (2010) Gremlin: vexing VEGF receptor agonist. Blood. 116(18):3386-7.
                          • Product nameProduct name
                            Size / Price
                            Catalog: 11066-RP01-100
                            List Price: 
                            Price:      (You Save: )

                            Datasheet & Documentation

                            All information of our products is subject to change without notice. Please refer to COA enclosed in shipped package for the newest information.
                            Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"